GMP Insights & Articles

Cleaning Validation Limits: Calculating MACO, PDE, and Swab Recovery Studies
Consulting

Cleaning Validation Limits: Calculating MACO, PDE, and Swab Recovery Studies

\n Multi-product manufacturing lines must prove zero toxicological carryover between product shifts. The regulatory expectation for cleaning validation is to prevent cross-contamination that could affect patient safety. This guide reviews ...

Nov 18, 2025 Read Article →
Quality Risk Management (ICH Q9): Structured FMEA and Process Auditing
Consulting

Quality Risk Management (ICH Q9): Structured FMEA and Process Auditing

\n ICH Q9 guidelines provide a systematic process for assessing, controlling, and reviewing quality risks. Quality Risk Management (QRM) has transitioned from a recommendation to a core requirement across international GMP guidelines. In t...

Oct 22, 2025 Read Article →
Out-of-Specification (OOS) Investigations: Laboratory Phase I Guidelines and FDA Compliance
Consulting

Out-of-Specification (OOS) Investigations: Laboratory Phase I Guidelines and FDA Compliance

\n Handling Out-of-Specification (OOS) laboratory data is one of the most critical aspects of FDA audit integrity. An OOS result occurs when an analytical test result falls outside the defined limits established in monographs, drug master ...

Sep 05, 2025 Read Article →
Equipment Qualification Lifecycle: URS, DQ, IQ, OQ, and PQ Validation
Consulting

Equipment Qualification Lifecycle: URS, DQ, IQ, OQ, and PQ Validation

\n Qualifying facility machinery ensures consistent output within GMP specs throughout its operation lifecycle. From large compounding tanks and clean steam generators to analytical balances in QC, every piece of GMP equipment must be qual...

Aug 12, 2025 Read Article →